KEY FINDINGS
The Europe Alzheimer's disease therapeutics and diagnostics market is estimated to record a CAGR of 5.59% during the forecast period, 2021-2028. The surging population is the main driver of market growth in the European region.
MARKET INSIGHTS
France, Poland, Russia, the United Kingdom, Italy, Belgium, Germany, and the rest of Europe, are assessed for the Europe Alzheimer's disease therapeutics and diagnostics market growth evaluation. In France, as of 2018, the number of dementia cases stood at 1,227,558, which is projected to double by 2050. Also, the aged population is set to witness an increase of 24.1% by 2030. In 2001, France was the first country in Europe to develop a national dementia strategy, which was further updated in 2004 and 2008. The country also created a network of 'memory centers,' highly specialized in diagnosing neurodegenerative disorders. There are currently more than 400 memory centers/consultation sites across the nation. Such factors are set to drive market growth.
In Germany, as per the German Federal Statistical Office 2020, there are almost 83 million people, of which 16.2 million are aged above 67, which is further projected to reach 21.4 million in 2040. The proximity of the aged population to neurological disorders, like dementia and Alzheimer's disease, is among the market growth drivers in the country. Moreover, regions like Saarland, Bavaria, Schleswig-Holstein, and Rhineland-Palatinate, are developing regional dementia plans that cover areas like improving awareness and early diagnosis. There is also an increasing focus on funding large research institutions by the federal government. In 2019, the Julich Research Center witnessed successful results in the first phase of human clinical testing of a new Alzheimer's drug. Such factors are projected to propel market growth in Germany.
COMPETITIVE INSIGHTS
Some of the key players in the market include, Pfizer Inc, Novartis AG, Merck & Co Inc, F. Hoffmann-La Roche, Lupin Limited, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Europe Alzheimer's Disease Therapeutics And Diagnostics Market Forecast 2021-2028
Table Of Contents
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Parent Market Analysis
3.2. Key Drivers
3.2.1. Growing Geriatric Population
3.2.2. Rise In The Pervasiveness Of Alzheimer's Disease
3.2.3. Emerging Novel Diagnostic Technologies
3.3. Key Restraints
3.3.1. Failure Of The Late-Stage Drugs
3.3.2. Lack Of The Availability Of Surrogate Markers
4. Key Analytics
4.1. Porter's Five Forces Analysis
4.1.1. Buyers Power
4.1.2. Suppliers Power
4.1.3. Substitution
4.1.4. New Entrants
4.1.5. Industry Rivalry
4.2. Impact Of Covid-19 On Alzheimer's Disease Therapeutics And Diagnostics Market
4.3. Key Buying Criteria
4.4. Etymology Of Alzheimer's Disease Therapeutics And Diagnostics Market
4.5. Supply Chain Analysis
4.6. Phases And Sternness Of Alzheimer's Disease
4.7. Opportunity Matrix
4.8. Vendor Landscape
4.9. Key Market Trends
5. Market By Therapeutics And Diagnostics
5.1. Therapeutics
5.1.1. Therapeutics By Drugs
5.1.1.1. Marketed Drugs
5.1.1.2. Pipeline Drugs
5.1.2. Therapeutics By Disease Stage
5.1.2.1. Late Stage: Severe Ad
5.1.2.2. Early/Middle Stage: Mild To Moderate Ad
5.1.2.3. Prodromal Stage
5.1.3. Therapeutics By Generic And Branded
5.1.3.1. Branded
5.1.3.2. Generic
5.2. Diagnostics
5.2.1. Lumbar Puncture Test
5.2.2. Positron Emission Tomography
5.2.3. Electroencephalography
5.2.4. Magnetic Resonance Imaging
5.2.5. Computed Tomography
5.2.6. Blood Test
5.2.7. Other Diagnostics
6. Geographical Analysis
6.1. Europe
6.1.1. Market Size & Estimates
6.1.2. Key Growth Enablers
6.1.3. Key Challenges
6.1.4. Key Players
6.1.5. Country Analysis
6.1.5.1. United Kingdom
6.1.5.2. France
6.1.5.3. Germany
6.1.5.4. Italy
6.1.5.5. Russia
6.1.5.6. Belgium
6.1.5.7. Poland
6.1.5.8. Rest Of Europe
7. Competitive Landscape
7.1. Key Strategic Developments
7.1.1. Mergers & Acquisitions
7.1.2. Product Launches & Developments
7.1.3. Partnerships, Contracts/Agreements & Collaborations
7.1.4. Business Expansions/ Approvals/ Announcements
7.2. Company Profiles
7.2.1. Allergan Plc (Acquired By Abbvie)
7.2.2. Amarantus Bioscience Holdings Inc
7.2.3. Baxter International Inc
7.2.4. Biogen Inc
7.2.5. Cognoptix Inc
7.2.6. Eisai Co Ltd
7.2.7. Eli Lilly & Company
7.2.8. F. Hoffmann-La Roche
7.2.9. Ge Healthcare
7.2.10. Johnson & Johnson
7.2.11. Lupin Limited
7.2.12. Merck & Co Inc
7.2.13. Novartis Ag
7.2.14. Pfizer Inc
7.2.15. Siemens Healthineers Ag
7.2.16. Sun Pharmaceuticals Industries Ltd
7.2.17. Teva Pharmaceutical Industries Limited
7.2.18. Zydus Cadila
List Of Tables
Table 1: Market Snapshot - Alzheimer's Disease Therapeutics And Diagnostics
Table 2: Europe Alzheimer's Disease Therapeutics And Diagnostics Market, By Therapeutics And Diagnostics, Historical Years, 2016-2020 (In $ Million)
Table 3: Europe Alzheimer's Disease Therapeutics And Diagnostics Market, By Therapeutics And Diagnostics, Forecast Years, 2021-2028 (In $ Million)
Table 4: Europe Therapeutics Market, By Drugs, Historical Years, 2016-2020 (In $ Million)
Table 5: Europe Therapeutics Market, By Drugs, Forecast Years, 2021-2028 (In $ Million)
Table 6: Europe Therapeutics Market, By Disease Stage, Historical Years, 2016-2020 (In $ Million)
Table 7: Europe Therapeutics Market, By Disease Stage, Forecast Years, 2021-2028 (In $ Million)
Table 8: Europe Therapeutics Market, By Generic And Branded, Historical Years, 2016-2020 (In $ Million)
Table 9: Europe Therapeutics Market, By Generic And Branded, Forecast Years, 2021-2028 (In $ Million)
Table 10: Europe Diagnostics Market, By Type, Historical Years, 2016-2020 (In $ Million)
Table 11: Europe Diagnostics Market, By Type, Forecast Years, 2021-2028 (In $ Million)
Table 12: Europe Alzheimer's Disease Therapeutics And Diagnostics Market, By Country, Historical Years, 2016-2020 (In $ Million)
Table 13: Europe Alzheimer's Disease Therapeutics And Diagnostics Market, By Country, Forecast Years, 2021-2028 (In $ Million)
Table 14: Leading Players Operating In The Europe Alzheimer's Disease Therapeutics And Diagnostics Market
Table 15: List Of Mergers & Acquisitions
Table 16: List Of Product Launches & Developments
Table 17: List Of Partnerships, Contracts/Agreements & Collaborations
Table 18: List Of Business Expansions/ Approvals/ Announcements
List Of Figures
Figure 1: Porter's Five Forces Analysis
Figure 2: Supply Chain Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Key Market Trends
Figure 6: Europe Alzheimer's Disease Therapeutics And Diagnostics Market, By Therapeutics, 2021-2028 ($ Million)
Figure 7: Europe Therapeutics Market, By Marketed Drugs, 2021-2028 ($ Million)
Figure 8: Europe Therapeutics Market, By Pipeline Drugs, 2021-2028 ($ Million)
Figure 9: Europe Therapeutics Market, By Late Stage, 2021-2028 ($ Million)
Figure 10: Europe Therapeutics Market, By Early/Middle Stage, 2021-2028 ($ Million)
Figure 11: Europe Therapeutics Market, By Prodromal Stage, 2021-2028 ($ Million)
Figure 12: Europe Therapeutics Market, By Branded, 2021-2028 ($ Million)
Figure 13: Europe Therapeutics Market, By Generic, 2021-2028 ($ Million)
Figure 14: Europe Alzheimer's Disease Therapeutics And Diagnostics Market, By Diagnostics, 2021-2028 ($ Million)
Figure 15: Europe Diagnostics Market, By Lumbar Puncture Test, 2021-2028 ($ Million)
Figure 16: Europe Diagnostics Market, By Positron Emission Tomography, 2021-2028 ($ Million)
Figure 17: Europe Diagnostics Market, By Electroencephalography, 2021-2028 ($ Million)
Figure 18: Europe Diagnostics Market, By Magnetic Resonance Imaging, 2021-2028 ($ Million)
Figure 19: Europe Diagnostics Market, By Computed Tomography, 2021-2028 ($ Million)
Figure 20: Europe Diagnostics Market, By Blood Test, 2021-2028 ($ Million)
Figure 21: Europe Diagnostics Market, By Other Diagnostics, 2021-2028 ($ Million)
Figure 22: Europe Alzheimer's Disease Therapeutics And Diagnostics Market, Country Outlook, 2020 & 2028 (In %)
Figure 23: United Kingdom Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Figure 24: France Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Figure 25: Germany Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Figure 26: Italy Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Figure 27: Russia Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Figure 28: Belgium Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Figure 29: Poland Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Figure 30: Rest Of Europe Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Global Alzheimer's Disease Drug Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 93
According to our LPI (LP Information) latest study, the global Alzheimer's Disease Drug market size was valued at US$ 3539.3 million in 2023. With growing demand in downstream market, the Alzheimer's Disease Drug is forecast to a readjusted size of US$ 3943.3 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Alzheimer's Disease Drug market. Alzheimer's Disease Drug are expected to show stable growth in the future m......
Alzheimer's Drugs - Global Market Insights and Sales Trends 2024
Published: 25-Dec-2023 Price: US 3350 Onwards Pages: 97
The global Alzheimer's Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Alzheimer's Drugs in various end use industries. The expanding demands from the Under 65 Years Old and 65 and Above 65 Years Old, are propelling Alzheimer's Drugs market. Acetylcholinesterase (AChE) Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by t......
Alzheimer Disease Drugs Industry Forecasts - China Focus
Published: 27-Nov-2023 Price: US 1800 Onwards Pages: 111
This study focuses on China's Alzheimer Disease Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and servi......
Alzheimer Disease Drugs Companies in China
Published: 27-Nov-2023 Price: US 1800 Onwards Pages: 74
This study focuses on China's Alzheimer Disease Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumpt......
Alzheimer Disease Drugs Markets in China
Published: 27-Nov-2023 Price: US 4000 Onwards Pages: 239
China's demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacit......
Global Alzheimer's Disease Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 12-Sep-2023 Price: US 3380 Onwards Pages: 117
Market Overview of Global Alzheimer's Disease Drug market:
According to our latest research, the global Alzheimer's Disease Drug market looks promising in the next 5 years. As of 2022, the global Alzheimer's Disease Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Alzheimer's disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills and,......
Global Dementia and Movement Disorder Treatment Market Insights, Forecast to 2029
Published: 11-Aug-2023 Price: US 4900 Onwards Pages: 110
Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality changes, difficulty in performing activities, loss of memory, and aphasia.
Market Analysis and Insights: Global Dementia and Movement Disorder Treatment Market
The global Dementia and Movement......
Global Nicergoline Market Insights, Forecast to 2029
Published: 04-Jul-2023 Price: US 4900 Onwards Pages: 112
The global Nicergoline market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Nicergoline is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Nicergoline is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR......
Global Oxiracetam Market Research Report 2023
Published: 21-Apr-2023 Price: US 2900 Onwards Pages: 69
Highlights
The global Oxiracetam market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Oxiracetam is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
